Health
New comparative performance data published for authorized COVID-19 molecular diagnostic tests – News-Medical.Net
Today, the U.S. Food and Drug Administration published comparative performance data for some authorized COVID-19 molecular diagnostic tests.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Today, the U.S. Food and Drug Administration published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The tables show the Limit of Detection (LoD) of more than 55 authorized molecular diagnostic COVID-19 tests against a standardized sample panel provided by the FDA.
The FDA provided these standardized samples, known as a reference panel, to test developers who are required to assess their test’s performance ag…
Continue Reading